AZNAX
Price
$12.33
Change
-$0.01 (-0.08%)
Updated
Jun 22 closing price
Net Assets
4.9B
RLBEX
Price
$40.69
Change
-$0.14 (-0.34%)
Updated
Jun 22 closing price
Net Assets
287.61B
Interact to see
Advertisement

AZNAX vs RLBEX

AZNAX vs RLBEX Comparison Chart in %
View a ticker or compare two or three
VS
AZNAX vs. RLBEX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZNAX is a StrongBuy and RLBEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 288B vs. AZNAX (4.91B). AZNAX pays higher dividends than RLBEX: AZNAX (2.07) vs RLBEX (1.77). AZNAX was incepted earlier than RLBEX: AZNAX (19 years) vs RLBEX (24 years). AZNAX (1.14) is less costly to investors than RLBEX (0.60). AZNAX is a more actively managed with annual turnover of: 76.00 vs. RLBEX (50.00). RLBEX has a lower initial minimum investment than AZNAX: RLBEX (250) vs AZNAX (2500). RLBEX (14.85) and AZNAX (14.45) have marching annual gain over last year. RLBEX return over 5 years is better than : 34.08 vs. AZNAX (4.30).
AZNAXRLBEXAZNAX / RLBEX
Total Expense Ratio1.140.60190%
Annual Report Gross Expense Ratio1.140.60190%
Fund Existence19 years24 years-
Gain YTD7.4668.25590%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.91B288B2%
Annual Yield % from dividends2.071.77117%
Returns for 1 year14.4514.8597%
Returns for 3 years26.4242.8262%
Returns for 5 years4.3034.0813%
Returns for 10 years42.4490.0947%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APRE0.790.08
+11.06%
Aprea Therapeutics
BIIB199.713.13
+1.59%
Biogen
CPRX31.390.01
+0.03%
Catalyst Pharmaceuticals
ESPR3.15N/A
N/A
Esperion Therapeutics
BZUN2.72-0.06
-2.33%
Baozun